FDA Investigator Christina V Santos
Christina V Santos has conducted inspections on 13 sites in 4 countries as of 26 Mar 2001. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
26 Mar 2001
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Germany,
United States of America,
Netherlands,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Christina V Santos:
Ademola O Daramola,
Alicia M Mozzachio,
Amalia C Himaya,
Angela Jourdain,
Anita Narula, PhD,
Ann Marie Montemurro,
Ann Marie Schofield,
Antonina Aydanian,
Arie C Menachem,
Barbara M Frazier,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Brenda L Reihing,
Brian D Nicholson,
Brien C Fox,
Bruce H Mccullough,
Bryce E Mansfield,
Burnell M Henry,
Carla J Lundi,
Carrie Ann Plucinski,
Caryn M Mcnab,
Catherine J Laufmann,
CDR Jeremy L Wally, PhD,
Chad R Burger,
Cheron M Portee,
Christian D Lynch (CDL),
Christina A Miller,
Christina C Santos,
Cody D Rickman,
Connie L Hannon Rabel,
Cynthia Jim, CSO,
Daniel W Cline,
David Perkins,
Davinna Ligons, PhD,
Deborah A Nebenzahl,
Debra I Love,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Dolores E Price,
Donna Ltartaglino Besone,
Dr. Guang Gao, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Robert C Horan, MD,
Esther C Broner, PhD,
Frances Namuswe, PhD,
Gene D Arcy,
Gerald N Mcgirl, DDS,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Helen B Ricalde,
Humera T Khan,
Iris C Macinnes,
Jacqueline Mdiaz Albertini,
James R Fleckenstein,
Jason F Chancey,
Jay Slater, MD,
Jeanne M Morris,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer L Bridgewater,
Jennifer M Gogley,
Joel Welch, PhD,
Joey V Quitania,
John E Emmert,
John R Myung,
Joyce A Rockwell,
Julie D Bringger,
Junho Pak,
Ka L Wong,
Kaarin M Slotte,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Kimberly M Bigler,
Laura Fontan, MS,
Leonard H Lavi,
Lequita M Mayhew,
Lisa M Bellows,
Lisa M Feola,
Lorelei S Jarrell,
Lori J Silverstein,
Lynda L Perry, PhD,
Madushini Dharmasena, PhD,
Marcia B Williams,
Marcus F Yambot,
Margaret M Annes,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Mariza M Jafary,
Mary E Farbman, PhD,
Mary T Carden,
Maxyne T Lam,
Meihong Liu,
Michelle A Marsh,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Mra Davism,
Mra Munizn,
Nancy A Saxenian Emmons,
Nicholas F Lyons,
Nicholas Obiri, PhD,
Nicholas P Diorio,
Nicola M Fenty Stewart,
Nicole J Clausen,
Nicole K Trudel,
Omotunde O Osunsanmi,
Paul M Kawamoto,
Paula A Trost,
Peggy M Speight,
Peter S Diak,
Philip E Ake,
Phung Thien Nguyen,
Prabhu P Raju,
Priscilla M Pastrana,
Qiao Y Bobo,
Ralph A Erickson,
Randall N Johnson,
Rebecca K Olin,
Rebecca Rodriguez,
Rebecca T Davis,
Reyes Candau Chacon, PhD,
Richmond K Yip,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert Darius,
Robert Jennings,
Rocco C Black,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Rose Ashley,
Russ R Rivy,
Russell K Riley,
S Lori Brown, PhD MPH,
Sarah Arden,
Scott R Nichols, PhD,
Sean Fitzsimmons,
Shafiq S Ahadi,
Sharon I Gundersen,
Shawn E Larson,
Sidney B Priesmeyer,
Simone E Pitts,
Sonia R Peterson,
Stanley Au,
Stephen D Brown,
Steven Fong, MS, PhD,
Susan M Jackson,
Susan P Bruederle,
Susan T Hadman,
Taichun Qin, PhD,
Tamika White,
Taruna Khurana,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thomas J Arista,
Thomas R Withers,
Thuy T Nguyen, LCDR,
Todd M Stankewicz,
Uttaniti Limchumroon (Tom),
Xiaojun Yan,
Xiaokuang Lai, PhD,
Yumi J Hiramine,
Yvonne C Wilkes
Christina V Santos's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2001 | EIR | Amgen, Inc - EIR, 2001-02-23 |
| December, 2000 | FDA 483 | ALLERMED LABORATORY, INC. - Form 483, 2000-12-15 |
| March, 2000 | FDA 483 Response | AbbVie Inc. - Form 483R, 2000-04-06 |
| February, 2000 | EIR | Lonza Biologics, plc - EIR, 2000-03-09 |
| March, 2000 | FDA 483 | AbbVie Inc. - Form 483, 2000-03-22 |
| July, 2000 | EIR | Organon Teknika B.V. - bioMerieux, BV - EIR, 2000-07-10 |
| February, 2001 | FDA 483 | Amgen, Inc - Form 483, 2001-02-23 |
| June, 2000 | FDA 483 | Organon Teknika b.v. - Form 483, 2000-07-10 |
| November, 2000 | FDA 483 | Alk-abello, Inc. - Form 483, 2000-11-02 |
| March, 2000 | EIR | AbbVie Inc. - EIR, 2000-03-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more